Choose between CoQ10 (ubiquinone) and Ubiquinol by age, statin use, and heart goal. After ~40, the body’s ability to convert ubiquinone to active ubiquinol declines — that’s where Ubiquinol justifies its 3× price. Under 40, ubiquinone works fine. Math, not medical advice.
Your situation
100 mg/day
Target daily dose (with fat-containing meal for absorption)
Form: Ubiquinone (CoQ10)
Ubiquinone vs Ubiquinol — the actual difference
| Ubiquinone (CoQ10) | Ubiquinol (reduced CoQ10) | |
|---|---|---|
| Form | Oxidized | Reduced (active) |
| Cost per 100mg | ~$0.20-0.40 | ~$0.80-1.50 |
| Bioavailability under 40 | Adequate (converts efficiently) | Slightly higher plasma but no clear endpoint benefit |
| Bioavailability 40+ | Lower (conversion declines) | Higher (pre-reduced, no conversion needed) |
| On statin | Conversion further impaired | Bypasses the impaired pathway |
| Heart failure (NYHA III-IV) | Some data (Q-SYMBIO used ubiquinone) | Preferred for severe CHF in some clinics |
| Stability | More stable; lighter sensitive | Less stable; light-sensitive |
| Practical pick | Default for under 40, no statin | 40+, on statin, CHF |
Trial-derived doses
| Goal | Dose | Source trial |
|---|---|---|
| General antioxidant | 100 mg/day | Common consumer maintenance |
| Statin myalgia (mixed evidence) | 100-200 mg/day | Banach 2015 meta-analysis (modest benefit) |
| CHF (NYHA II-IV) | 300 mg/day split | Q-SYMBIO 2014 (Mortensen): mortality reduction with 100mg × 3 |
| Migraine prevention | 100 mg × 3/day | Sandor 2005, Hershey 2007 |
| Female fertility (over 35) | 200-600 mg/day | Bentov 2014, Xu 2018 |
| Male fertility | 200-400 mg/day | Safarinejad 2009 |
| Hypertension (modest BP reduction) | 100-200 mg/day | Rosenfeldt 2007 meta-analysis (~17 mmHg systolic) |
| Periodontal disease | 60 mg/day | Smaller trials; topical also studied |
Absorption tips
- ALWAYS take with food containing fat. CoQ10 (both forms) is highly lipid-soluble — empty-stomach absorption is poor. A meal with avocado, olive oil, or fish 3-5× absorption.
- Split doses over 100 mg. Absorption saturates at single doses — taking 200 mg as 2 × 100 mg gives higher plasma than 1 × 200 mg.
- Softgels in oil base over dry powder/tablets. Oil-based softgels absorb 2-3× better.
- Solubilized formulations (Q-Gel, BioQuinone) show even better absorption — useful for higher therapeutic doses.
- Storage: ubiquinol degrades faster than ubiquinone. Keep in original packaging; don’t transfer to clear pill organizer for long periods.
Drug interactions and contraindications
- Warfarin: CoQ10 structurally resembles vitamin K — may reduce warfarin effect → reduced INR → increased clot risk. Major interaction; monitor INR closely or avoid combination.
- Antihypertensives: CoQ10 modestly lowers BP. Combined with multiple BP meds → additive hypotension risk.
- Diabetes meds: CoQ10 may modestly lower blood glucose. Monitor more closely if combining.
- Chemotherapy: mixed signals on CoQ10 effect on doxorubicin (cardioprotective in some studies, theoretical concern about reducing oxidative damage to tumors). Coordinate with oncologist.
- Pregnancy/breastfeeding: limited safety data; most clinicians recommend avoidance unless clearly indicated.
- Statins themselves: deplete endogenous CoQ10 by 30-50% within weeks. Doesn’t mean every statin user needs supplementation — only those with symptoms (myalgia) or specific risk factors.